How Neutrophils Drive DNA Damage Linked to Cancer
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
Browsing: "Pathology"
Scientists Discover New Heart Attack Repair Pathway
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing and tissue repair after heart attack, in a study published in Cell Metabolism.
Critical Mass
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
An Exceptional Cancer Center
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
New Therapeutic Target for Metabolic Disorders
Scientists have identified a novel regulator of liver metabolism, which could serve as a potential therapeutic target for obesity, type 2 diabetes and related conditions.
Mechanisms Driving Inherited Heart Disease
Northwestern Medicine scientists have identified a novel mechanism for how mutations in desmoplakin — a protein that helps cells stick together — can lead to cardiac arrhythmias and other diseases.
Feinberg Faculty to Lead Neuropathology Society
Two Northwestern faculty, including the chair of Pathology, will serve as president and vice president of the American Association of Neuropathologists.
Common Antimicrobial May Raise Risk of Colon Disease
Triclosan, a common antimicrobial used in toothpastes and other products, may raise the risk of gut inflammation and colorectal cancer, according to a preliminary animal study.
Precision Pathologist
New chair Daniel Brat, MD, PhD, is spearheading transformations in pathology, a field that’s rapidly evolving in parallel with advances in precision medicine and a trend toward sub-specialization.
Machines See the Future for Patients Diagnosed With Brain Tumors
Scientists have developed software that can forecast the survival of patients diagnosed with glioma that is more accurate than physicians’ predictions.